Cargando…
A Sarcoma at the Site of Previous Extravasation of Adriamycin
We report the case of a 66-year-old man presenting with a high-grade pleomorphic sarcoma at the left elbow 16 years after the extravasation of adriamycin given for a malignant ifbrous histiocytoma of the tibia.We suggest that this sarcoma originated in a multistep way over many years, out of the chr...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395497/ https://www.ncbi.nlm.nih.gov/pubmed/18521350 http://dx.doi.org/10.1080/1357714021000066386 |
_version_ | 1782155520187039744 |
---|---|
author | Ceulemans, Joris De Wever, Ivo Sciot, Raf Debiec-Rychter, Maria van Oosterom, Allan T. |
author_facet | Ceulemans, Joris De Wever, Ivo Sciot, Raf Debiec-Rychter, Maria van Oosterom, Allan T. |
author_sort | Ceulemans, Joris |
collection | PubMed |
description | We report the case of a 66-year-old man presenting with a high-grade pleomorphic sarcoma at the left elbow 16 years after the extravasation of adriamycin given for a malignant ifbrous histiocytoma of the tibia.We suggest that this sarcoma originated in a multistep way over many years, out of the chronic inflammatory tissue that developed due to a non-specific cellular damage at the nuclear level, interfering with normal cell replication necessary for normal healing tissue healing. As a result, the non-healed chronic inflammatory tissue transformed over several years into a preneoplastic mesenchymal tumour and later into a high-grade pleomorphic sarcoma. |
format | Text |
id | pubmed-2395497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23954972008-06-02 A Sarcoma at the Site of Previous Extravasation of Adriamycin Ceulemans, Joris De Wever, Ivo Sciot, Raf Debiec-Rychter, Maria van Oosterom, Allan T. Sarcoma Research Article We report the case of a 66-year-old man presenting with a high-grade pleomorphic sarcoma at the left elbow 16 years after the extravasation of adriamycin given for a malignant ifbrous histiocytoma of the tibia.We suggest that this sarcoma originated in a multistep way over many years, out of the chronic inflammatory tissue that developed due to a non-specific cellular damage at the nuclear level, interfering with normal cell replication necessary for normal healing tissue healing. As a result, the non-healed chronic inflammatory tissue transformed over several years into a preneoplastic mesenchymal tumour and later into a high-grade pleomorphic sarcoma. Hindawi Publishing Corporation 2002-12 /pmc/articles/PMC2395497/ /pubmed/18521350 http://dx.doi.org/10.1080/1357714021000066386 Text en Copyright © 2002 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ceulemans, Joris De Wever, Ivo Sciot, Raf Debiec-Rychter, Maria van Oosterom, Allan T. A Sarcoma at the Site of Previous Extravasation of Adriamycin |
title | A Sarcoma at the Site of Previous Extravasation of Adriamycin |
title_full | A Sarcoma at the Site of Previous Extravasation of Adriamycin |
title_fullStr | A Sarcoma at the Site of Previous Extravasation of Adriamycin |
title_full_unstemmed | A Sarcoma at the Site of Previous Extravasation of Adriamycin |
title_short | A Sarcoma at the Site of Previous Extravasation of Adriamycin |
title_sort | sarcoma at the site of previous extravasation of adriamycin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395497/ https://www.ncbi.nlm.nih.gov/pubmed/18521350 http://dx.doi.org/10.1080/1357714021000066386 |
work_keys_str_mv | AT ceulemansjoris asarcomaatthesiteofpreviousextravasationofadriamycin AT deweverivo asarcomaatthesiteofpreviousextravasationofadriamycin AT sciotraf asarcomaatthesiteofpreviousextravasationofadriamycin AT debiecrychtermaria asarcomaatthesiteofpreviousextravasationofadriamycin AT vanoosteromallant asarcomaatthesiteofpreviousextravasationofadriamycin AT ceulemansjoris sarcomaatthesiteofpreviousextravasationofadriamycin AT deweverivo sarcomaatthesiteofpreviousextravasationofadriamycin AT sciotraf sarcomaatthesiteofpreviousextravasationofadriamycin AT debiecrychtermaria sarcomaatthesiteofpreviousextravasationofadriamycin AT vanoosteromallant sarcomaatthesiteofpreviousextravasationofadriamycin |